While a nervous stock market may be looking for safe places to wait out the economic turbulence in the world, health care does not look like that sort of safe haven these days. Hospitals are spending more than they were a year or two ago, but it is not as though purse strings are uniformly loose. Likewise, while most people still have jobs and continue to see their doctors, enough people have lost jobs or insurance coverage to make an impact on the volumes of health care companies that depend on routine visits. Hologic (Nasdaq:HOLX) is all about routine care (with a capital equipment kicker) and while this remains an attractive franchise, momentum is still soft.
Slow Progress in the Third Quarter
Hologic beat the top end of the analyst range for third quarter revenue, but 7% sales growth is still not likely to get investors too excited. GYN Surgery was a growth leader at nearly 11%, but Hologic's largest unit (Breast Health) was up better than 8% as well. Diagnostics and skeletal health were both up in the low single digits.
Continue by clicking the link below:
http://stocks.investopedia.com/stock-analysis/2011/Hologic-Holding-Its-Place-HOLX-GE-SI-PHG-JNJ-BDX-CPTS-0808.aspx
No comments:
Post a Comment